Seres Therapeutics, Inc. (MCRB)
16.98
+0.20
(+1.19%)
USD |
NASDAQ |
Dec 10, 16:00
16.92
-0.06
(-0.38%)
Pre-Market: 20:00
Seres Therapeutics Market Cap: 148.65M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 304.95M |
| Palatin Technologies, Inc. | 23.82M |
| Theriva Biologics, Inc. | 7.473M |
| Oragenics, Inc. | 0.7965M |
| NanoViricides, Inc. | 23.76M |
Market Cap Related Metrics
| PE Ratio | 27.97 |
| PS Ratio | 421.84 |
| Price to Book Value | 3.402 |
| Price | 16.98 |
| Earnings Yield | 3.58% |
| Normalized PE Ratio | 27.97 |